Effects of Rhythm-Based Music on Pregnancies With Gestational Diabetes
Launched by ESIN CEBER TURFAN, PROFESSOR · May 6, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how rhythm-based music can help women who have gestational diabetes during pregnancy. Gestational diabetes is a type of diabetes that occurs only while pregnant, and it can lead to increased anxiety, which may affect both the mother's and baby's health. The researchers want to find out if listening to rhythm-based music or doing music and breathing exercises can reduce anxiety and improve blood sugar levels and stress hormones.
To participate, women must be over 18, in their third trimester of pregnancy, and currently diagnosed with gestational diabetes. The study will include 180 participants, who will be randomly assigned to one of three groups: two will take part in music activities, while the third will receive standard care. During a 3-day hospital stay, researchers will assess anxiety and measure blood sugar levels several times a day, as well as collect samples to check stress hormone levels. This trial may show that music is a helpful, non-drug option for managing anxiety and health during pregnancy.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Voluntarily agree to participate in the study with informed written consent
- • Diagnosed with Gestational Diabetes Mellitus (GDM) and currently hospitalised
- • In the third trimester of pregnancy
- • Over the age of 18
- • Have a live, single fetus
- Exclusion Criteria:
- • Any condition preventing participation in rhythm-based music making and listening (e.g., hearing, vision, or speech impairments)
- • Regular and routine music listening habits during pregnancy
- • Physical limitations or restrictions
- • Mental or cognitive disorders requiring medication
- • Use of corticosteroids or medications containing corticosteroids
- • Known fetal abnormalities
- • Systemic diseases other than GDM (e.g., Hypertension, Type 1 or Type 2 Diabetes, Thyroid disorders, etc.)
- • Body mass index (BMI) of 30 or higher
- • Discharge from the hospital before the 3rd day of the intervention
About Esin Ceber Turfan, Professor
Professor Esin Ceber Turfan is a distinguished clinical trial sponsor with extensive expertise in medical research and clinical methodologies. As a leader in her field, she is committed to advancing healthcare through rigorous scientific inquiry and innovative trial designs. Her work emphasizes ethical standards, patient safety, and the generation of reliable data to inform clinical practices. With a strong academic background and a collaborative approach, Professor Turfan fosters partnerships that enhance the quality and impact of clinical research, ultimately aiming to improve patient outcomes and contribute to the advancement of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
İzmir, , Turkey
Patients applied
Trial Officials
Esin Ceber Turfan, Prof
Principal Investigator
Ege University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported